Proposed Data Collections Submitted for Public Comment and Recommendations
Health and Human Services Department; Centers for Disease Control and Prevention · 2011
Read Proposed Data Collections Submitted for Public Comment and Recommendations by Health and Human Services Department; Centers for Disease Control and Prevention (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-14147.txt.
Description
Notice published in the Federal Register on 2011-06-08 by Health and Human Services Department; Centers for Disease Control and Prevention. Text from federalregister.gov (official edition: govinfo). [Pages 33303-33304] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-14147] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-11-11GU] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of.
Catalog record
| CREATOR | Health and Human Services Department; Centers for Disease Control and Prevention |
|---|---|
| YEAR | 2011 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Proposed Data Collections Submitted for Public Comment and Recommendations
Citation: us:fr:2011-14147
Creator: Health and Human Services Department; Centers for Disease Control and Prevention
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/06/08/2011-14147/proposed-data-collections-submitted-for-public-comment-and-recommendations
Context: Notice published in the Federal Register on 2011-06-08 by Health and Human Services Department; Centers for Disease Control and Prevention. Text from federalregister.gov (official edition: govinfo).
[Pages 33303-33304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-14147]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-11-11GU]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Daniel Holcomb, CDC Reports Clearance Officer,
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Survey of Rapid Influenza Diagnostic Test (RIDT) Practices in
Clinical Laboratories--New--the Office of Surveillance, Epidemiology,
and Laboratory Services (OSELS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Survey of Rapid Influenza Diagnostic Testing Practices in
Clinical Laboratories is a national systematic study investigating
rapid influenza diagnostic testing practices in clinical
[[Page 33304]]
laboratories. The survey will be funded in full by the Office of
Surveillance, Epidemiology, and Laboratory Services (OSELS) of the
Centers for Disease Control and Prevention (CDC). Influenza epidemics
usually cause an average more than 200,000 hospitalizations and 36,000
deaths per year in the U.S. Respiratory illnesses caused by influenza
viruses are not easily differentiated from other respiratory infections
based solely on symptoms. Also influenza viruses may adversely affect
different subpopulations. The effective use of rapid influenza
diagnostic testing practices is an important component of the
differential diagnosis of influenza-like-illness in both inpatient and
outpatient treatment facilities. Test results are used for making
decisions about antiviral vs. antibiotic use, and in making admission
or discharge decisions. In many cases, rapid influenza tests are the
only tests that can provide results while the patient is still present
in the facility. Thus, the appropriate use of the tests, and
interpretation of test results is critical to the treatment and control
of influenza. More than a dozen rapid tests have been approved by the
U.S. Food and Drug Administration and are in widespread use. The
reliability of rapid influenza tests is influenced by the individual
test product used and the setting. Reported sensitivities range from
10-75%; while the median specificities reported are 90-95%. Other
factors influencing accuracy are the stage (or duration) of illness
when the diagnostic specimen is collected, type and adequacy of the
specimen collected, variability in user technique for specimen
collection or assay performance, and disease activity in the community.
Given these and other collective findings, it is imperative for public
health and for response planning that CDC develops sector-specific
guidance and effective outreach to the clinicians on appropriate use of
RIDT in their practices.
Previous studies by CDC of outpatient facilities showed that
clinical laboratories usually perform the rapid tests for emergency
departments, and provide results for both inpatient and outpatient
treatment. Thus, understanding the use of rapid influenza testing in
clinical laboratories, how the laboratories report results to emergency
departments and treatment facilities and health departments, and what
quality assurance practices are used will guide future efforts of the
CDC to develop appropriate influenza testing guidelines and sector-
specific training materials for clinicians and improve health outcomes
of the American public.
The survey covers basic laboratory demographic characteristics,
specimen collection and processing, testing practices, reporting of
results to emergency departments and other treatment facilities,
reporting results to health departments, quality assurance practices,
and methods of receiving updated influenza-related information. The
majority of the questions request information about laboratory
influenza testing practices.
To date, no systematic study has been conducted to investigate how
laboratories use these tests, how they report results, or how they
interact with outpatient treatment facilities. The survey will be
conducted on a national sample of clinical laboratories. There are no
costs to respondents except their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Avg. burden
Type of respondents Form name No. of responses per per response Total burden
respondents respondent (in hrs) (in hrs)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Clinical Laboratory Supervisors................ Survey of Rapid Influenza Diagnostic 600 1 30/60 300
Test Practices in Clinical
Laboratories.
--------------------------------------------------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 300
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: June 1, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-14147 Filed 6-7-11; 8:45 am]